Skip to content
WeighLab
Grade B−

Pepti Review: Price, Pros & Cons

By The WeighLab Bench, Tools & Data Desk

Pepti sells compounded semaglutide from $99 a month at the starting dose and tirzepatide from $159, with every dose step priced on the page and the doctor, labs and shipping included.

Read the full review

This page is the Pepti scorecard, with the most recent prices we've checked. Our full review goes deeper on how its plans, billing and policies work: Pepti Review: $99 Semaglutide to Start, and What Each Dose Costs After That.

Visit Pepti Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$99/mo0.25 mg starting dose, compounded; $109–$199 at higher doses
Tirzepatide
$159/mo2.5 mg starting dose, compounded; $179–$319 at higher doses
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$1,287

13 charges a year: billed every four weeks

Tirzepatide · modeled / year

$2,067

13 charges a year: billed every four weeks

The Index scorecard

Pepti scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month81/100
Price Transparency84/100
Nationwide Access86/100
Formulation Options66/100
Clinical Oversight86/100
Contract Flexibility67/100

Where the value is

  • Every dose has its own published price: semaglutide runs $99 to $199 and tirzepatide $159 to $319
  • No membership fee; the medication price includes physician review, dose adjustments and free shipping
  • Names a reviewing physician and a dispensing pharmacy, Olympia Pharmacy
  • Cancel any time with no cancellation fee, and you can pause for up to 90 days
  • Posts third-party lab results for recent semaglutide lots on the product page

The tradeoffs

  • The price rises as your dose goes up, so the $99 starting figure covers only the first step of semaglutide
  • It bills every 28 days rather than monthly, which adds up to 13 charges a year
  • You pay at checkout before a provider reviews your intake; you're refunded if you're declined
  • No prorated refunds, and medication can't be refunded once it ships
  • The wider catalog includes peptides such as melanotan II that aren't approved drugs
  • Compounded semaglutide and tirzepatide are not FDA-approved products

The bottom line

Best for: Shoppers who want to see the price of every dose step before they start, with no membership fee on top. Pepti sells compounded semaglutide from $99 a month at the starting dose and tirzepatide from $159, with every dose step priced on the page and the doctor, labs and shipping included.

For comparison, read our review of CoreAge Rx, one of our partners. Partners are listed first on our leaderboard; every provider is scored on the same six factors.

Other programs to compare with Pepti

These are partners: we may earn a commission if you sign up, at no cost to you.

  • Enhance MDPartner

    Semaglutide from $212/mo · tirzepatide from $280/mo

    Enhance MD charges $212 a month for compounded semaglutide and $280 for tirzepatide at every dose, with lab work every six months included; the first month is $100 less.

  • HealthRXPartner

    Semaglutide from $190/mo · tirzepatide from $239/mo

    HealthRX charges $190 a month for compounded semaglutide and $239 for tirzepatide month to month; the $99 and $179 it advertises are prepaid twelve-month prices.

  • SkinnyRxPartner

    Semaglutide from $249/mo · tirzepatide from $299/mo

    SkinnyRx charges $99 for the first month of compounded semaglutide or tirzepatide, then $249 or $299 a month; prepaid plans bring semaglutide down to $199 a month.

Compare with other providers

The providers whose Cost-Efficiency Index scores sit closest to Pepti's. See the alternatives to Pepti.

The 21 programs nearest this one

Pricing, states and verification reflect Pepti's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Pepti's site. Not medical advice; see our disclosure.

← Back to the value leaderboard